GC4419

Galera's stock plunges 73% on disappointing test results for lead cancer drug candidate
Bizjournals
Tue, 10/19/21 - 10:53 am
Galera Therapeutics
cancer
clinical trials
head and neck cancer
oral mucositis
GC4419
Galera claims positive update in pancreatic cancer but doesn't report p-values
Endpoints
Thu, 04/29/21 - 10:46 am
Galera Therapeutics
pancreatic cancer
GC4419